The Koch Institute Clinical Investigator program offers physician-scientists a unique opportunity to participate in cutting-edge cancer research while continuing their medical practice and provides Koch Institute researchers with a frontline view of challenges in cancer treatment. This roundtable discussion with past and present Clinical Investigators explores the relationship between laboratory benchwork and clinical translation and practice.

Register on Zoom

Featured Presenters:

Scott Floyd, MD, PhD
Gary Hock and Lyn Proctor Associate Professor of Radiation Oncology, Duke University
Assistant Research Professor in Pharmacology and Cancer Biology, Duke University Cancer Center

Salil Garg, MD, PhD
Charles W. (1955) and Jennifer C. Johnson Clinical Investigator, Koch Institute
Pathologist, Massachusetts General Hospital

Hojun Li, MD, PhD
Charles W. (1955) and Jennifer C. Johnson Clinical Investigator, Koch Institute
Attending Physician, Dana Farber/Boston Children’s Hospital Cancer and Blood Disorders Center

Alice Tsang Shaw, MD, PhD
Global Head of Translational Clinical Oncology, Novartis
Attending Physician, Center for Thoracic Cancers, Massachusetts General Hospital

Moderated by Michael B. Yaffe, MD, PhD
Director, Koch Institute Clinical Investigators Program
David H. Koch Professor of Science, Professor of Biology and Biological Engineering, MIT
Surgical Intenstivist, Division of Acute Care Surgery and Critical Care, Beth Israel Deaconess Medical Center